Yi Yao

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 5

Top Topics

Tyrosine Kinase

Circulating Tumor

Loop Mediated Isothermal Amplification

Top Venues

Cancer management and research

Oxidative medicine and cellular longevity

Journal of hepatocellular carcinoma

This page only lists publications with an associated author ORCID identifier.

Publications

Lina Yi, Yingmei Wen, Mengxia Xiao, Jingping Yuan, Xiaokang Ke, Xiuyun Zhang, Liaqat Khan, Qibin Song, Yi Yao
The proportion of tumour stroma predicts response to treatment of immune checkpoint inhibitor in combination with chemotherapy in patients with stage IIIB-IV non-small cell lung cancer. Histopathology (2024)
Lina Yi, Yingmei Wen, Mengxia Xiao, Jingping Yuan, Xiaokang Ke, Xiuyun Zhang, Liaqat Khan, Qibin Song, Yi Yao
The proportion of tumour stroma predicts response to treatment of immune checkpoint inhibitor in combination with chemotherapy in patients with stage IIIB-IV non-small cell lung cancer. Histopathology 85 (2) (2024)
Yanjun Gao, Yingge Li, Zheming Liu, Yi Dong, Siqi Yang, Bin Wu, Mengxia Xiao, Chen Chen, Yingmei Wen, Lei Chen, Haijuan Jiang, Yi Yao
AHSA1 Regulates Hepatocellular Carcinoma Progression via the TGF-β/Akt-Cyclin D1/CDK6 Pathway. Journal of hepatocellular carcinoma 10 (2023)
Jin Zhou, Zheming Liu, Huibo Zhang, Tianyu Lei, Jiahui Liu, Yaqi Zhao, Yi Yao, Qibin Song
BACH1: A Potential Predictor of Survival in Early-Stage Lung Adenocarcinoma. Oxidative medicine and cellular longevity 2022 (2022)
Na Li, Hao Zuo, Luojun Chen, Huali Liu, Jin Zhou, Yi Yao, Bin Xu, Hong-Yun Gong, Yiming Weng, Qinyong Hu, Qibin Song, Min Peng, Yanxiang Cheng
Circulating Tumor Cell Detection In Epithelial Ovarian Cancer Using Dual-Component Antibodies Targeting EpCAM And FRα. Cancer management and research 11 (2019)